Medical oncology: Clinical value of circulating tumor cells in breast cancer

Nature Reviews Clinical Oncology

Volumn 8, Issue 12, 2011, Pages 696-698

  Sleijfer, Stefan ^a   Foekens, John A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2 INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CELL FUNCTION; CELL HETEROGENEITY; CIRCULATING TUMOR CELL; DRUG POTENCY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION PROFILING; HUMAN; IMMUNOMAGNETIC SEPARATION; MOLECULAR DYNAMICS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TREATMENT RESPONSE;

BREAST NEOPLASMS; FEMALE; HUMANS; INDIVIDUALIZED MEDICINE; MEDICAL ONCOLOGY; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS;

EID: 82555187094     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2011.167     Document Type: Article

References (10)

1. Pantel, K., Alix-Panabieres, C. & Riethdorf, S. Cancer micrometastases. Nat. Rev. Clin. Oncol. 6, 339-351 (2009).
2. Cristofanilli, M. et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351, 781-791 (2004).
3. Cristofanilli, M. et al. Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J. Clin. Oncol. 23, 1420-1430 (2005).
4. Pantel, K. & Alix-Panabieres, C. Circulating tumor cells in cancer patients: Challenges and perspectives. Trends Mol. Med. 16, 398-406 (2010).
5. Perou, C. M. et al. Molecular portraits of human breast tumors. Nature 406, 747-752 (2000).
6. Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750-2767 (2011).
7. Sieuwerts, A. M. et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J. Natl Cancer Inst. 101, 61-66 (2009).
8. Mostert, B. et al. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. Breast Cancer Res. Treat. 127, 33-41 (2010).
9. Giordano, A. et al. Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: Lack of prediction in HER2-positive disease treated with targeted therapy. Ann. Oncol. http://dx.doi.org/10.1093/ annonc/mdr434.
10. Sieuwerts, A. M. et al. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients. Clin. Cancer Res. 17, 3600-3618 (2011).